Healius (ASX: HLS) – Agilex Biolabs sold to Novotech 2
Healius Limited has agreed to sell its subsidiary Agilex Biolabs to Novotech for an enterprise value of A$160 million, according to an ASX...
Healius Limited has agreed to sell its subsidiary Agilex Biolabs to Novotech for an enterprise value of A$160 million, according to an ASX...
Netwealth Group Limited has been served with a class action statement of claim relating to certain First Guardian investment options offered through...
Ramsay Health Care has announced plans to demerge its Ramsay Santé European operations through an in-specie distribution to shareholders, subject to...
Sonic Healthcare reported a strong financial year with underlying net profit rising 17% to A$621 million on revenue growth of 13%, including organic...
Metrics Master Income Trust has announced a monthly distribution of AUD 0.0130 per ordinary unit for the period ending 30 September 2026. The...